ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 289 • 2013 ACR/ARHP Annual Meeting

    Development and Validation Of The Cutoff Values For Disease Activity States Of The Three-Item Version Of The Juvenile Arthritis Disease Activity Score

    Alessandro Consolaro1, Sara Verazza1, Maria C. Gallo1, Giulia Bracciolini1, Giorgia Negro1, Alessia Frisina1, Nicolino Ruperto2, Alberto Martini1,3 and Angelo Ravelli1,3, 1Pediatria II, Istituto Giannina Gaslini, Genova, Italy, 2PRINTO, Genoa, Italy, 3Department of Pediatrics, University of Genova, Genova, Italy

    Background/Purpose: A new approach to the measurement of disease activity in juvenile idiopathic arthritis (JIA) is based on the Juvenile Arthritis Disease Activity Score (JADAS).…
  • Abstract Number: 290 • 2013 ACR/ARHP Annual Meeting

    Children With JIA Show Distinct Patterns Of Improvement In Their Health-Related Quality Of Life During The First Year On Treatment: Growth Mixture Modeling Of a Prospective Cohort Of Newly Diagnosed Patients

    Bin Huang1, Chen Chen2, Stacey Niehaus3, Hermine Brunner4, Rina Mina5 and Michael Seid6, 1Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center/University of Cincinnati School of Medicine, Cincinnati, OH, 2Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 3Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 4Cincinnati Children's Hospital Medical Center/University of Cincinnati School of Medicine, Cincinnati, OH, 5Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 6Pulmonary, Cincinnati Children's Hospital Medical Center/University of Cincinnati School of Medicine, Cincinnati, OH

    Background/Purpose: Health-related quality of life (HRQOL) is a key outcome in clinical care and research for children with JIA.  Despite excellent clinical control and the…
  • Abstract Number: 292 • 2013 ACR/ARHP Annual Meeting

    Body Surface Area-Based Dosing Approach Produced Comparable Golimumab Exposure Across Different Age Ranges After Subcutaneous Administration Of Golimumab In Pediatric Patients With Juvenile Idiopathic Arthritis

    Jocelyn H. Leu1, Alan M. Mendelsohn2, Joyce Ford1, Hugh M. Davis1 and Zhenhua Xu1, 1Janssen Research & Development, LLC., Spring House, PA, 2Immunology, Janssen Research & Development, LLC., Spring House, PA

    Background/Purpose:   To evaluate the pharmacokinetics (PK) of body surface area (BSA)-adjusted dosing of SC golimumab 30 mg/m2 every 4 weeks (q4w) + methotrexate (MTX)…
  • Abstract Number: 293 • 2013 ACR/ARHP Annual Meeting

    The Efficacy Of Etanercept In Patients With Juvenile Idiopathic Arthritis With Inadequate Response To Infliximab As a First TNF Inhibitor

    Ekaterina Alekseeva1,2, Tatyana Bzarova3, Anna Fetisova3, Tatyana Sleptsova3, Saniya Valieva3, Kseniya Isayeva3, Rina Denisova3, Elena Mitenko3, Evgeniya Chistyakova3 and Nikolay Taybulatov4, 1PRINTO, Genoa, Italy, 2I.M.Sechenov First Moscow State Medical University, Moscow, Russia, 3Rheumatology, Scientific Center of Children's Health of RAMS, Moscow, Russia, 4Orthopedic, Scientific Center of Children's Health of RAMS, Moscow, Russia

    Background/Purpose: Lack of efficacy of Methotrexate, primary and secondary resistance to biologics and their intolerance lead to juvenile idiopathic arthritis (JIA) of progression. Therefore, the problem of…
  • Abstract Number: 294 • 2013 ACR/ARHP Annual Meeting

    Physical Activity In Children With Juvenile Idiopathic Arthritis (JIA): The LEAP (Linking Exercise, Activity and Pathophysiology in Childhood Arthritis) Study

    Lori B. Tucker1, Heather A. McKay2, Leanne M. Ward3, Jaime Guzman1, Adam Baxter-Jones4, Kiem Oen5, Alan M. Rosenberg6, Johannes Roth3, Elizabeth Stringer7, Rae SM Yeung8, Kristin M. Houghton9, Heather Macdonald10, Debbie Ehrmann Feldman11, Ciaran M. Duffy12 and LEAP Study Investigators13, 1Rheumatology, BC Children's Hospital and University of British Columbia, Vancouver, BC, Canada, 2Family Practice and Orthoepedics, University of British Columbia, Vancouver, BC, Canada, 3University of Ottawa, Ottawa, ON, Canada, 4College of Kinesiology, University of Saskatchewan, Saskatoon, SK, Canada, 5University of Manitoba, Winnipeg, MB, Canada, 6Department of Pediatrics, University of Saskatchewan, Saskatoon, SK, Canada, 7Department of Rheumatology, IWK Health Centre, Halifax, NS, Canada, 8Rheumatology, The Hospital for Sick Children and University of Toronto, Toronto, ON, Canada, 9University of British Columbia, Vancouver, BC, Canada, 10The University of British Columbia, Vancouver, BC, Canada, 11Rehabilitation, Université de Montréal, Montreal, QC, Canada, 12Rheumatology, Children's Hospital of Eastern Ontario and University of Ottawa, Ottawa, ON, Canada, 13BC Children's Hospital, Vancouver, BC, Canada

    Background/Purpose:   Although children with JIA have lower fitness levels than healthy peers, little is known about their level of habitual physical activity.   The LEAP…
  • Abstract Number: 295 • 2013 ACR/ARHP Annual Meeting

    Uveitis In The Nordic Juvenile Idiopathic Arthritis Cohort; High Incidence, Frequent Complications, and Gender Associated Risk Factors

    Ellen Nordal1,2, Lillemor Berntson3, Kristiina Aalto4, Suvi Peltoniemi5, Susan Nielsen6, Troels Herlin7, Anders Fasth8 and Marite Rygg9,10, 1Department of Pediatrics, University Hospital of North Norway, Tromsø, Norway, 2Department of Clinical Medicine, University of Tromsø, Tromsø, Norway, 3Department of Pediatrics, Uppsala University Hospital, Uppsala, Sweden, 4Department of Pediatrics,, Helsinki University Children's Hospital, Helsinki, Finland, 5Department of Pediatrics, Helsinki University Children's Hospital, Helsinki, Finland, 6Pediatric Rheumatology Unit, Juliane Marie Centret, Rigshospitalet, Copenhagen, Denmark, 7Pediatric Rheumatology Clinic, Department of Pediatrics, Aarhus University Hospital, Aarhus, Denmark, 8Department of Pediatrics, University of Gothenburg, Gothenburg, Sweden, 9Department of Laboratory Medicine, Children's and Women's health, Norwegian University of Science and Technology, Trondheim, Norway, 10Department of Pediatrics, St Olav University Hospital, Trondheim, Norway

    Background/Purpose: Uveitis is the most common extra-articular manifestation of juvenile idiopathic arthritis (JIA). Both incidence and reported outcome varies, and population-based data are scarce. Early…
  • Abstract Number: 296 • 2013 ACR/ARHP Annual Meeting

    Declines In Levels Of Disease Activity and Physical Disability In Children With Juvenile Idiopathic Arthritis Seen In Standard Clinical Care Over The Last 25 Years

    Alessandro Consolaro1, Stefano Lanni1, Francesca Minoia1, Sergio Davì1, Sara Dalprà1, Benedetta Schiappapietra1, Rossana Pignataro1, Cristina Ferrari1, Alberto Martini1,2 and Angelo Ravelli3,4, 1Pediatria II, Istituto Giannina Gaslini, Genova, Italy, 2Department of Pediatrics, University of Genova, Genova, Italy, 3PRINTO, Genoa, Italy, 4University of Genova, Genova, Italy

    Background/Purpose: Over the last 3 decades there have been important advances in the management of juvenile idiopathic arthritis (JIA), which include the introduction of methotrexate…
  • Abstract Number: 297 • 2013 ACR/ARHP Annual Meeting

    Plasma Nicotinamide Phosphoribosyltransferase Correlates With Markers Of Inflammation and May Predict Early Therapeutic Response To Low-Dose Methotrexate In Juvenile Idiopathic Arthritis

    Ryan S. Funk1, Leon van Haandel1, Marcia Chan2, Lanny J. Rosenwasser2, Andrew Lasky3, Maria F. Ibarra4, Mark F. Hoeltzel5, S.Q. Ye6, J.S. Leeder1 and Mara L Becker7, 1Clinical Pharmacology and Medical Toxicology, Children's Mercy Hospital, Kansas City, MO, 2Pediatric Immunology Research, Children's Mercy Hospital, Kansas City, MO, 3Pediatrics Rheumatology, Children's Mercy Hospital, Kansas City, MO, 4Pediatric Rheumatolgy, Children's Mercy Hospital, Kansas City, MO, 5Rheumatology Section, Children's Mercy Hospital, Kansas City, MO, 6Medical Genetic Research, Children's Mercy Hospital, Kansas City, MO, 7Clinical Pharmacology and Rheumatology, Children's Mercy Hospital, Kansas City, MO

    Background/Purpose:   Despite a poor understanding of its biochemical role in the inflammatory process, nicotinamide phosphoribosyltransferase (NAMPT) has been implicated in a number of autoimmune…
  • Abstract Number: 298 • 2013 ACR/ARHP Annual Meeting

    Preliminary Prospective Study Of Ultrasonography In Patients With Juvenile Idiopathic Arthritis In Clinical Remission: Subclinical Synovitis May Predict Flare?

    Vanessa B Miotto e Silva1, Sônia A.V. Mitraud2, Rita NV Furtado3, Jamil Natour3 and Maria Teresa Terreri1, 1Pediatrics, Escola Paulista de Medicina/ Universidade Federal de São Paulo, São Paulo, Brazil, 2Radiology and Diagnostic Imaging, Escola Paulista de Medicina/ Universidade Federal de São Paulo (EPM/UNIFESP), São Paulo, Brazil, 3Internal Medicine, Escola Paulista de Medicina/ Universidade Federal de São Paulo, São Paulo, Brazil

    Background/Purpose: Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic disease in childhood and has variable prognosis, characterized by periods of activity and remission.…
  • Abstract Number: 299 • 2013 ACR/ARHP Annual Meeting

    Phenotypic Cluster Analysis Of Juvenile Idiopathic Arthritis: Relationship To International Leagues Of Associations For Rheumatology Classification Criteria

    Jay Mehta1, Juan Lin2, Norman T. Ilowite3,4 and for The CARRA Registry Investigators5, 1Pediatrics, Children's Hospital at Montefiore/Albert Einstein College of Medicine, Bronx, NY, 2Epidemiology & Population Health, Albert Einstein College of Medicine, Bronx, NY, 3Pediatrics, Albert Einstein College of Medicine, Bronx, NY, 4Pediatrics, The Children's Hospital at Montefiore, Bronx, NY, 5Multiple Affiliations, Palo Alto, CA

    Phenotypic cluster analysis of Juvenile Idiopathic Arthritis: relationship to ILAR classification criteriaBackground/Purpose: The ILAR classification of Juvenile Idiopathic Arthritis (JIA) delineated categories of childhood chronic…
  • Abstract Number: 268 • 2013 ACR/ARHP Annual Meeting

    Inflammatory Bowel Disease In Juvenile Idiopathic Arthritis Patients Upon Biologics

    Deborah Barthel1 and Gerd Horneff2, 1Paediatrics, Asklepios Clinic Sankt Augustin, Sankt Augustin, Germany, 2Department of Pediatrics, Centre of Pediatric Rheumatology, Sankt Augustin, Germany

    Background/Purpose: Inflammatory bowel disease (IBD) is a matter of interest in patients with juvenile idiopathic arthritis (JIA) treated with biologics. Methods: Baseline demografics, clinical characteristics…
  • Abstract Number: 260 • 2013 ACR/ARHP Annual Meeting

    Pain, Functional Impairment and Ultrasound Detected Changes In Patients With Erosive and Non-Erosive Hand Osteoarthritis

    Olga Sleglova1, Olga Ruzickova2, Karel Pavelka3 and Ladislav Senolt4, 1Institute of Rheumatology, Prague, Prague, Czech Republic, 2Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Prague, Czech Republic, 3Institute of Rheumatology and Department of Rheumatology, 1st Medical Faculty, Charles University Prague, Prague, Czech Republic, 4Institute of Rheumatology, Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic

    Background/Purpose: Hand osteoarthritis (HOA) is a common and frequent cause of pain. HOA is a heterogeneous group of disorders with two main subsets including non-erosive…
  • Abstract Number: 261 • 2013 ACR/ARHP Annual Meeting

    Concordance Of Hip Pain With Radiographic Hip Osteoarthritis In An Urban US Community: The Framingham Osteoarthritis Study

    Kyu Chan Kim1, David T. Felson2, Katherine D. Linsenmeyer3, Ali Guermazi4, Steven C. Vlad5, Mary M. Clancy6 and Jingbo Niu7, 1Internal Medicine and Rheumatology, Boston Medical Center, Boston, MA, 2Clinical Epidemiology Unit, Boston University School of Medicine, Boston, MA, 3Internal Medicine, Boston Medical Center, Boston, MA, 4Boston University, Boston, MA, 5Clinical Epidemiology, Boston University, Boston, MA, 6School of Medicine, Boston University, Boston, MA, 7Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, MA

    Background/Purpose: While it is well known that knee pain and radiographic knee osteoarthritis (OA) are often discordant, little is known of the concordance of hip…
  • Abstract Number: 262 • 2013 ACR/ARHP Annual Meeting

    Is There a Role For Non-Mendelian Inheritance In Severe Osteoarthritis Of The Knee

    Allen D. Sawitzke1, Richard Pimentel2, Jathine Wong2, Helena Martinez3, Marta Herrero3, Josep Verges4 and Daniel O. Clegg5, 1Rheumatology, University of Utah, Salt Lake City, UT, 2University of Utah, Salt Lake, UT, 3Pharmascience Division, Bioiberica S.A., Barcelona, Spain, 4Pharmacological Research Unit, Scientific Medical Department, Bioibérica, S.A., Barcelona, Spain, 5Rheumatology, George Wahlen VA Medical Center/University of Utah, Salt Lake City, UT

    Background/Purpose: Although the etiopathogenesis of osteoarthritis of the knee remains largely unknown, it is clear that genetic risks are contributory. Traditional family, twin, case control…
  • Abstract Number: 263 • 2013 ACR/ARHP Annual Meeting

    “Generalized Osteoarthritis”: A Systematic Review

    Amanda E. Nelson1, Michael W. Smith2 and Yvonne M. Golightly3, 1University of North Carolina Thurston Arthritis Research Center, Chapel Hill, NC, 2Rheumatology, Saint Luke's Hospitals, Kansas City, MO, 3Gillings School of Global Public Health, Dept of Epidemiology, Thurston Arthritis Research Center, Injury Prevention Research Center, University of North Carolina Dept of Epidemiology, Chapel Hill, NC

    Background/Purpose: To perform a systematic review of definitions, risk factors, and outcomes in "generalized osteoarthritis" (GOA). Methods: We performed a systematic review of Medline literature…
  • « Previous Page
  • 1
  • …
  • 2228
  • 2229
  • 2230
  • 2231
  • 2232
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology